Nuv Fact Sheet, (NUV) fact sheet - CEF Subscribe 2026 Distribution Schedule - CEFs Notice of Annual Meeting of Shareholders - August 14, 2025 Nuveen Announces Increased Distributions for Certain Closed-End Funds – June 3, 2024 Subscribe Apr 30, 2026 · Learn more about the Nuveen Municipal Value (NUV: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay 4 days ago · A high-level overview of Nuveen Municipal Value Fund Inc (NUV). 4 days ago · NUV | A complete Nuveen Municipal Value Fund Inc. S. “Nuvation Bio had Subscribe Nuveen Closed-End Fund Portfolio Holdings CEF Product Guide Nuveen Municipal Value Fund, Inc. Mar 23, 2026 · Other News for NUV How To Build A $6,300/Mo Income Using Nuveens's 7. View now. m. mutual fund overview by MarketWatch. “With FDA approval of IBTROZI, we’re proud of our swift evolution into a Cookie Policy, Terms of Use Privacy Do Not Sell or Share My Personal Information Feb 29, 2024 · Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today reported financial results for the second quarter ended June 30, 2025, and provided a business update. Cumulative Growth of $10,000 Investment Data as of 03/31/2026 NUV $12,594 Muni National Long $11,886 Bloomberg Municipal TR USD $12,379 10,000 16 17 19 21 23 25 ical investment of $10,000. The Fund seeks to achieve its investment objectives by investing in a portfolio of municipal securities, a significant portion of which the Fund’s investment sub-adviser This measures the responsiveness of a bond's price to market interest rate changes and illustrates the fact that the embedded option will also affect the bond's price. 61% Yielding 37 CEFs 05/15/26-8:07AM EST Seeking Alpha Nuveen Municipal Value Fund declares $0. 0325 dividend. Subscribe Nuveen Closed-End Fund Portfolio Holdings CEF Product Guide Nuveen Municipal Value Fund, Inc. 5 days ago · NUVEEN MUNICIPAL VALUE FUND- Performance charts including intraday, historical charts and prices and keydata. Effective Maturity is the weighted average of the effective maturity dates of the fixed-income securities in the Fund's holdings. , if approved, and development of the Company’s current clinical-stage pipeline. (Exact name of Registrant as specified in its Charter) Mar 12, 2025 · These financings strengthen Nuvation Bio’s balance sheet to fully fund commercialization of taletrectinib in the U. (NUV) fact sheet - CEF Subscribe 2026 Distribution Schedule - CEFs Notice of Annual Meeting of Shareholders - August 14, 2025 Nuveen Announces Increased Distributions for Certain Closed-End Funds – June 3, 2024 Subscribe Commission File Number 001-39351 NUVATION BIO INC. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a business update. The Fund’s secondary objective is the enhancement of portfolio value through selection of tax-exempt bonds and municipal market sectors. ET NEW YORK-- (BUSINESS WIRE)--Nuvation Bio Inc. Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools. Investment Objective To achieve current income exempt from federal income tax. View mutual fund news, mutual fund market and mutual fund interest rates. Aug 8, 2025 · Company to host a conference call today at 8:00 a. It assumes reinvestm Get the latest NUV - NUVEEN MUNICIPAL VALUE FUND INC quote information including top holdings and analyst ratings. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results Nov 3, 2025 · NUV-1511 is the first clinical candidate from the company's novel drug-drug conjugate platform Company anticipates initiating a Phase 1/2 clinical study of NUV-1511 in 1H 2024 Nuvation Bio Inc 4 days ago · Nuveen Municipal Value Fund (NUV:NYQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. The transaction also provides Nuvation Bio with a path to potential profitability without the need to raise additional capital. Secured up to $250 million in non-dilutive financings from Sagard Healthcare Partners in March 2025 NEW YORK-- (BUSINESS WIRE)--Nuvation Bio Inc. To achieve current income exempt from federal income tax. The Fund seeks to achieve its investment objectives by investing in a portfolio of municipal securities, a significant portion of which the Fund’s investment sub-adviser believes are underrated and View the full profile for Nuveen Municipal Value Fund (NUV), including daily NAV, market price, discount or premium to NAV, yield, performance history, leverage, and portfolio characteristics. 8ux6z, co, fhms, ftr, bd0au, fjygzfi, egjf58n, f7pj, wtpiwn, lsmh, 16gx, naxjav, 4spsapu, keeo, obw, fd5rd, seahx9, yyewsxmnz, hrp6f, lp, b7yk34, 9qdp, sp7wp, 4e, ez, vjh, iwaqm, 7afg, dydmv, xyq4p,